Orgenesis Price on January 19, 2024
ORGSDelisted Stock | USD 1.22 0.31 20.26% |
If you're considering investing in Orgenesis OTC Stock, it is important to understand the factors that can impact its price. As of today, the current price of Orgenesis stands at 1.22, as last reported on the 24th of December, with the highest price reaching 1.55 and the lowest price hitting 1.10 during the day. Orgenesis maintains Sharpe Ratio (i.e., Efficiency) of -0.37, which implies the firm had a -0.37% return per unit of risk over the last 3 months. Orgenesis exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Orgenesis' Coefficient Of Variation of (587.98), risk adjusted performance of (0.13), and Variance of 127.61 to confirm the risk estimate we provide.
Orgenesis OTC Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Orgenesis |
Sharpe Ratio = -0.3665
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns | ORGS |
Estimated Market Risk
13.78 actual daily | 96 96% of assets are less volatile |
Expected Return
-5.05 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
-0.37 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Orgenesis is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Orgenesis by adding Orgenesis to a well-diversified portfolio.
Related Headline
Acrivon Therapeutics, Headline on 19th of January 2024
Filed transaction by Acrivon Therapeutics Inc officer. Payment of exercise price or tax liability by delivering or withholding securities
Orgenesis Valuation on January 19, 2024
It is possible to determine the worth of Orgenesis on a given historical date. On January 19, 2024 Orgenesis was worth 3.07 at the beginning of the trading date compared to the closed value of 2.82. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Orgenesis otc stock. Still, in general, we apply an absolute valuation method to find Orgenesis' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Orgenesis where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Orgenesis' related companies.
Open | High | Low | Close | Volume | |
3.20 | 3.30 | 3.00 | 3.21 | 11,458 | |
01/19/2024 | 3.07 | 3.10 | 2.50 | 2.82 | 13,308 |
2.80 | 3.20 | 2.60 | 3.20 | 11,598 |
Backtest Orgenesis | | | Orgenesis History | | | Orgenesis Valuation | Previous | Next |
Orgenesis Trading Date Momentum on January 19, 2024
On January 22 2024 Orgenesis was traded for 3.20 at the closing time. The top price for the day was 3.20 and the lowest listed price was 2.60 . The trading volume for the day was 11.6 K. The trading history from January 22, 2024 was a factor to the next trading day price appreciation. The trading delta at closing time against the next closing price was 13.48% . The trading delta at closing time against the current closing price is 20.57% . |
Orgenesis Fundamentals Correlations and Trends
By evaluating Orgenesis' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Orgenesis' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Orgenesis financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Orgenesis OTC Stock history
Orgenesis investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Orgenesis is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Orgenesis will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Orgenesis stock prices may prove useful in developing a viable investing in Orgenesis
Orgenesis Inc., a biotech company, focusing on cell and gene therapies worldwide. Orgenesis Inc. was incorporated in 2008 and is based in Germantown, Maryland. Orgenesis operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 151 people.
Orgenesis OTC Stock Technical Analysis
Orgenesis technical otc stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, otc market cycles, or different charting patterns.
Price Boundaries
Orgenesis Period Price Range
Low | December 24, 2024
| High |
0.00 | 0.00 |
Orgenesis cannot be verified against its exchange. Please verify the symbol is currently traded on OTCQB Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Orgenesis December 24, 2024 Market Strength
Market strength indicators help investors to evaluate how Orgenesis otc stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Orgenesis shares will generate the highest return on investment. By undertsting and applying Orgenesis otc stock market strength indicators, traders can identify Orgenesis entry and exit signals to maximize returns
Orgenesis Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Orgenesis' price direction in advance. Along with the technical and fundamental analysis of Orgenesis OTC Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Orgenesis to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | (0.13) | |||
Jensen Alpha | (1.89) | |||
Total Risk Alpha | (2.26) | |||
Treynor Ratio | 1.13 |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in price. Note that the Orgenesis information on this page should be used as a complementary analysis to other Orgenesis' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Other Consideration for investing in Orgenesis OTC Stock
If you are still planning to invest in Orgenesis check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Orgenesis' history and understand the potential risks before investing.
Commodity Directory Find actively traded commodities issued by global exchanges | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Stocks Directory Find actively traded stocks across global markets |